RAR Ratio Linked to Higher Mortality Risk in CKD Patients

Quantifying Mortality Risks Associated With Elevated RAR in Kidney Disease

Higher RAR values substantially increase the risk of both overall death and cardiovascular mortality among individuals diagnosed with chronic kidney disease. Patients falling into the highest quartile of RAR carry greater adjusted risks for all-cause death, marked by a hazard ratio of 2.69, and cardiovascular disease death, with a hazard ratio of 2.86, when compared to those in the lowest quartile. These statistical relationships remain consistent even after applying propensity score matching to balance baseline characteristics.

Additional research published in JAMA Network Open by Hao, Jiang, Tang, and colleagues, alongside a study in Scientific Reports by Kimura, Tanaka, Saito, and co-authors, further explores the prognostic value of the red blood cell distribution width-albumin ratio across different patient populations. While the association with cancer mortality follows a linear trajectory, the relationships connecting RAR to all-cause and cardiovascular mortality display a nonlinear pattern.

Threshold Analysis Identifies a Critical Inflection Point at 4.258

Researchers conducted a threshold analysis that isolated a specific inflection point at an RAR value of 4.258. Below this numeric threshold, the hazard ratios sit at 2.32 for both all-cause mortality and cardiovascular disease mortality. Once patient values rise above this 4.258 threshold, however, the direct associations lose statistical significance.

Subgroup Findings Vary Across Albuminuria Levels and Age Groups

The link between RAR and all-cause mortality shifts depending on the severity of a patient’s albuminuria, yielding a statistically significant interaction. The prognostic signal appears weaker among participants suffering from macroalbuminuria, where the hazard ratio drops to 1.30. In contrast, patients with normoalbuminuria face a hazard ratio of 2.16, and those with microalbuminuria show a hazard ratio of 1.99.

The study authors note that marked hypoalbuminemia in patients with severe kidney damage can obscure the underlying inflammatory signal typically carried by red blood cell distribution width. Consequently, clinicians must interpret the prognostic value of RAR cautiously when evaluating patients who present with macroalbuminuria. Associations prove stronger among adults aged 65 years or older regarding both overall mortality and cancer mortality.

Methodological Limitations and Biomarker Interpretation

Investigators acknowledge several limitations inherent to their study design. Because the researchers measured RAR only a single time, the data does not capture longitudinal changes over the course of the disease. Unmeasured confounding variables, such as iron supplementation regimens and various prescription medications, may also influence the clinical outcomes.

The observational nature of the research restricts investigators from establishing direct causal conclusions. The study authors emphasize that clinicians should interpret RAR strictly as a prognostic biomarker for tracking mortality outcomes rather than viewing it as a modifiable risk factor. Future evaluation requires prospective cohorts and randomized controlled trials to validate these prognostic markers before widespread clinical adoption.